Linde stock faces valuation test as Lincare weighs on growth

Published on 11/12/2026 at 17:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Linde is repairing its Lincare home care business while protecting its long-term growth model. Investors are watching the path to a stronger 2027 outlook.

Lincare keeps growth in focus

Linde is restructuring its U.S. home care business while reviewing strategic options.
Management links a successful repair of Lincare to a return to double-digit adjusted EPS growth.
The next major test is the companys 2027 adjusted EPS outlook expected with the February 2027 report.

Linde, IE000S9YS762, Illustration mit AI erstellt.

Linde is facing a valuation test as pressure from its U.S. home care business weighs on the companys near-term growth profile. In a report published Wednesday, November 11, Yahoo Finance, citing Trefis, said Lincare had reduced Linde's 2026 earnings-per-share growth by 1.5% to 2% and that management expects savings from the restructuring to come on top of normal productivity gains.

Linde stock traded at 475.80 euros on Lang & Schwarz at 17:11 CET on Thursday, November 12, 2026, 0.68 percent above the Xetra close of Wednesday, November 11.

Lincare remains the key swing factor

Linde recorded a 425 million US dollar restructuring charge in the third quarter. About half related to severance, while most of the remainder involved portfolio and asset actions at Lincare. Management is evaluating strategic options, but the fourth-quarter outlook assumes no meaningful profit improvement from the unit.

The company guides adjusted earnings per share growth of 8% to 9% for 2026, or 6% to 7% excluding currency effects. Management has said that removing the Lincare drag could support a return to double-digit adjusted EPS growth, making the units operational recovery central to the longer-term investment case.

Valuation raises the execution hurdle

Trefis put Linde's trailing earnings multiple at 34.3, compared with 22.3 for the S&P 500. That spread leaves less room for execution setbacks: investors must weigh the potential benefit of restructuring against weaker industrial conditions and the absence of a material near-term profit contribution from Lincare.

The next major checkpoint is Linde's 2027 adjusted EPS outlook, expected with its February 2027 results. Investors will look for evidence that severance savings are emerging without weakening the companys broader productivity program.